Curis | CRIS - Current Assets


Curis reported $16.61M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Alaunos Therapeutics USD 666K 304K Jun/2026
Amgen USD 34.36B 598M Sep/2026
AstraZeneca USD 31.45B 3.48B Sep/2026
Bayer EUR 39.6B 5.96B Sep/2026
Bristol-Myers Squibb USD 29.77B 1.19B Sep/2026
CSL USD 11.85B 1000K Dec/2025
Curis USD 16.61M 9.7M Mar/2026
Eli Lilly USD 65.26B 591M Sep/2026
Exelixis USD 1.32B 70.8M Sep/2026
Gilead Sciences USD 16.55B 4.02B Sep/2026
GlaxoSmithKline GBP 17.9B 336M Sep/2026
Incyte USD 5.52B 505.2M Sep/2026
Merck USD 38.94B 2.26B Sep/2026
Novartis USD 28.75B 1.4B Sep/2026
Pfizer USD 45.01B 3.65B Sep/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sanofi EUR 33.21B 1.68B Sep/2026
Takeda JPY 3T 153.11B Sep/2026
TG Therapeutics USD 1.15B 58.72M Jun/2026
Verastem USD 202.9M 20.51M Mar/2026